MedTrace Logo

Multicenter Prospective Cumulus Cell Test Study

NCT02962466 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2018-10-30

No results posted yet for this study

Summary

Performing an additional non invasive oocyte diagnostic test based on cumulus gene expression could improve the outcome of the ART cycle.

Conditions

  • Pregnancy

Interventions

OTHER

CC-Test

classification of the oocyte based on the expression pattern observed in the cumulus cells

Sponsors & Collaborators

  • Universitair Ziekenhuis Brussel

    lead OTHER

Principal Investigators

  • Tom Adriaenssens, Msc · Universitair Ziekenhuis Brussel

  • Johan Smitz, Prof. Dr. · Universitair Ziekenhuis Brussel

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-30
Primary Completion
2019-11-30
Completion
2020-11-30

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02962466 on ClinicalTrials.gov